IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis

por Perimenis, Philippos, Galaris, Apostolos, Voulgari, Alexandra, Prassa, Margarita, Pintzas, Alexander
Publicado 2016